CFG
LLY icon

Cambridge Financial Group’s Eli Lilly LLY Stock Holding History

Cambridge Financial Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-65,033
Closed -$4.68M – 32
2016
Q1 		$4.68M Sell
65,033
-3,961
-6% -$300K 2.91% 29
2015
Q4 		$5.81M Sell
68,994
-1,457
-2% -$121K 3.48% 12
2015
Q3 		$5.9M Buy
+70,451
New +$5.95M 3.53% 10

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Cambridge Financial Group's LLY Position: Q2 2016 in Review

Cambridge Financial Group sold out of Eli Lilly (LLY) in Q2 2016, closing a stake of 65,033 shares — an estimated $4.68M sold.

Cambridge Financial Group first reported a position in LLY in Q3 2015 and held it in 3 quarters. The position peaked at $5.9M in Q3 2015. 1,179 funds tracked by Wall St. Rank hold LLY as of Q2 2016.

  • Cambridge Financial Group reported no remaining Eli Lilly position as of Q2 2016 after selling out during the quarter.
  • Cambridge Financial Group sold 65,033 Eli Lilly shares in Q2 2016, an estimated $4.68M.
  • Cambridge Financial Group first reported a position in Eli Lilly in Q3 2015 and held it in 3 quarters.
  • Cambridge Financial Group's Eli Lilly position peaked at $5.9M in Q3 2015.
  • 1,179 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2016.

Based on Cambridge Financial Group's 13F filing for Q2 2016, filed 17 Aug 2016.